Cargando…
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health
Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease (CVD) often cluster together as “Cardiometabolic Disease” (CMD). Just under 50% of patients with CMD increased the risk of morbidity and mortality right from the beginning of the COVID-19 pandemic as it has been reported...
Autores principales: | Lo Presti, Elena, Nuzzo, Domenico, Al Mahmeed, Wael, Al-Rasadi, Khalid, Al-Alawi, Kamila, Banach, Maciej, Banerjee, Yajnavalka, Ceriello, Antonio, Cesur, Mustafa, Cosentino, Francesco, Firenze, Alberto, Galia, Massimo, Goh, Su-Yen, Janez, Andrej, Kalra, Sanjay, Kapoor, Nitin, Kempler, Peter, Lessan, Nader, Lotufo, Paulo, Papanas, Nikolaos, Rizvi, Ali A., Sahebkar, Amirhossein, Santos, Raul D., Stoian, Anca P., Toth, Peter P., Viswanathan, Vijay, Rizzo, Manfredi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510069/ https://www.ncbi.nlm.nih.gov/pubmed/36174875 http://dx.doi.org/10.1016/j.bbadis.2022.166559 |
Ejemplares similares
-
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact
por: Kapoor, Nitin, et al.
Publicado: (2022) -
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
por: Rosta, Laszlo, et al.
Publicado: (2023) -
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence
por: Mainas, Giuseppe, et al.
Publicado: (2022) -
Post-COVID syndrome, inflammation, and diabetes()
por: Rizvi, Ali A., et al.
Publicado: (2022) -
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel
por: Jensterle, Mojca, et al.
Publicado: (2022)